✦ LIBER ✦

Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma

✍ Scribed by Nobile, M.T; Rosso, R; Sertoli, M.R; Rubagotti, A; Vidili, M.G; Guglielmi, A; Venturini, M; Canobbio, L; Fassio, T; Gallo, L

Book ID: 122787373
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 618 KB
Volume: 28
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(92)90013-R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I–II study of 14-days continuous

A phase I–II study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinoma

✍ Sinnige, Harm A.M.; Nanninga, Afien G.; Verschueren, Rene C.J.; Sleijfer, Dirk T 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 535 KB

A prospective randomized comparison of p

A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid-atlantic oncology program study

✍ Jacob J. Lokich; James D. Ahlgren; James Cantrell; William J. Heim; Galen L. Wam 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

A phase II study of continuous infusion

A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma

✍ Jean L. Grem; Nanette McAtee; Frank Balis; Robert Murphy; David Venzon; Barnett 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

A comprehensive review of 5-fluorouracil

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

✍ David Machover 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Background: Colorectal carcinoma is the third leading cause of cancer-related death. the primary treatment for patients with metastatic colorectal carcinoma is systemic chemotherapy with 5-fluorouracil (5-fu) and leucovorin (lv), a biomodulator of 5-fu that has been shown to enhance its activity

A phase III study of recombinant interle

A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma

✍ S.D. Heys; o. Eremin; E.M. Ruggeri; F. Pein; H. Rainer; R. Oskam; R.A. de Peuter 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 854 KB

Comparison of 5-fluorouracil with 5-fluo

Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma

✍ Frederick Richards II; Thomas L. Pajak; Miles R. Cooper; Charles L. Spurr 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the